Pfizer Says New COVID Pill Cut Severe Disease by 89%
FRIDAY, Nov. , 2021 (HealthDay News) — Pfizer Inc. announced Friday that its experimental COVID-19 pill slashed the risk of hospitalization and death by 89% in infected high-risk people. The five-day treatment, when given within three days of infection, was so effective in a clinical trial that an independent monitoringContinue Reading